Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Acinar Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03986294
What this trial is testing

Second Line Treatment With Nal-IRI and S1 in Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 122
Testing effectiveness (Phase 2)Study completedNCT03611556
What this trial is testing

MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study.

Who this might be right for
CarcinomaMetastatic Pancreatic Adenocarcinoma
MedImmune LLC 213
Not applicableUnknownNCT04709445
What this trial is testing

Perfusion Rate Assessment by Near-infrared Fluorescence in Gastrointestinal Anastomoses

Who this might be right for
Bowel ObstructionBowel IschemiaDiverticulitis+9 more
Charite University, Berlin, Germany 100
Testing effectiveness (Phase 2)UnknownNCT06345300
What this trial is testing

NALIRIFOX in Combination With Camrelizumab for BRPC: a Prospective, Exploratory Study

Who this might be right for
Borderline Resectable Pancreatic Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 40
Very early researchUnknownNCT05886075
What this trial is testing

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors

Who this might be right for
Lung CancerBronchial CancerNon Small Cell Lung Cancer+9 more
Shanghai Yunying Medical Technology 24
Testing effectiveness (Phase 2)Ended earlyNCT01888965
What this trial is testing

Maintenance Dovitinib for Colorectal and Pancreas Cancer

Who this might be right for
Colorectal CancerPancreas Cancer
Georgetown University 9
Not applicableUnknownNCT05327400
What this trial is testing

Expression and Clinical Significance of IGHD in Pancreatic Cancer

Who this might be right for
Gene Expression
Affiliated Hospital of Nantong University 30
Testing effectiveness (Phase 2)Looking for participantsNCT06427239
What this trial is testing

Exploratory Clinical Study of HRS-4642 Combined With Adebrelimab in the Treatment of Advanced Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Cancer
Fudan University 130
Testing effectiveness (Phase 2)Study completedNCT00416767
What this trial is testing

Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery

Who this might be right for
Gastrointestinal Carcinoid TumorIslet Cell TumorNeoplastic Syndrome
Federation Francophone de Cancerologie Digestive 20
Large-scale testing (Phase 3)WithdrawnNCT04037241
What this trial is testing

Study of Anti-CEA CAR-T + Chemotherapy VS Chemotherapy Alone in Patients With CEA+Pancreatic Cancer & Liver Metastases

Who this might be right for
Malignant Tumor of Pancreas Metastatic to Liver
Sorrento Therapeutics, Inc.
Testing effectiveness (Phase 2)Study completedNCT03891472
What this trial is testing

Clinical Phase II Clinical Study Evaluating the Toxicity and Efficacy of mFOLFIRINOX Associated With SBRT (Stereotactic Radiotherapy) in Patients With Unresectable Locally Advanced Pancreatic Cancer

Who this might be right for
Cancer of PancreasUnresectable Pancreatic CancerChemotherapy Effect+1 more
Medical University of Silesia 40
Testing effectiveness (Phase 2)Study completedNCT03693677
What this trial is testing

First Line Metastatic Pancreatic Cancer : 5FU/LV+Nal-IRI, Gemcitabine+Nab-paclitaxel or a Sequential Regimen of 2 Months 5FU/LV+Nal-IRI

Who this might be right for
Metastatic Pancreatic Cancer
Federation Francophone de Cancerologie Digestive 288
Not applicableUnknownNCT05923567
What this trial is testing

New Predictive Marker for Pancreatic Cancer Using CA19-9 and Fecal Elastase

Who this might be right for
Paancreatic Cancer
Gangnam Severance Hospital 150
Testing effectiveness (Phase 2)Study completedNCT01210911
What this trial is testing

Metformin Combined With Chemotherapy for Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic CancerMetastatic Pancreatic Cancer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 120
Testing effectiveness (Phase 2)Looking for participantsNCT06411795
What this trial is testing

Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy

Who this might be right for
Duodenal NeoplasmPancreatic Neoplasm
Masonic Cancer Center, University of Minnesota 78
Early research (Phase 1)Study completedNCT01189929
What this trial is testing

Gemcitabine and Demcizumab (OMP-21M18) With or Without Abraxane® as 1st-line Treatment in Subjects With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
OncoMed Pharmaceuticals, Inc. 57
Not applicableStudy completedNCT05226572
What this trial is testing

Repeated EUS-guided Fine Needle Biopsy of Pancreatic Masses After Non-diagnostic or Inconclusive Results

Who this might be right for
Pancreatic AdenocarcinomaPancreas CancerPancreas Metastases
University of Bologna 462
Early research (Phase 1)Looking for participantsNCT06400472
What this trial is testing

Sofe-M in Participants With Selected Advanced Solid Tumors

Who this might be right for
Ovarian NeoplasmsEndometrial NeoplasmsUterine Cervical Neoplasms+4 more
Eli Lilly and Company 575
Not applicableUnknownNCT03770559
What this trial is testing

The Therapeutic Evaluation(Both Short-term and Long-term Outcome) of Minimal Invasive Radical Antegrade Modular Pancreatosplenectomy for Left-sided Pancreatic Cancer Patients

Who this might be right for
Pancreatic CancerSurgery
Peking Union Medical College Hospital 125
Testing effectiveness (Phase 2)Study completedNCT04431258
What this trial is testing

ABTL0812 in Combination With FOLFIRINOX for First-line Treatment of Metastatic Pancreatic Study

Who this might be right for
Pancreatic Cancer
Ability Pharmaceuticals SL 150
Next Page